Company: CCCP
Filing Date: 2025-05-15
Form Type: 10-Q
Source: 0001477932-25-003752
Chunk: 13

Company: Crona Corp.
Filing Date: 2025-05-15
Form: 10-Q
Item: Part I, Item 1
Chunk 13
---
 the auditor’s report providing additional information about the audit and the financial statements (i.e., an auditor discussion and analysis) unless the SEC determines that the application of such additional requirements is necessary or appropriate in the public interest, after considering protection of investors, and whether the action will promote efficiency, competition and capital formation; Submit certain executive compensation on matters to shareholder advisory votes, such as “say-on-pay” and “say-on-frequency;”

Disclose certain executive compensation related items such as the correlation between executive compensation and performance and comparisons of the CEO’s compensation to median employee compensation.

In addition, Section 107 of the JOBS Act also provides that an emerging growth company can take advantage of the extended transition period provided in Section 7(a)(2)(B) of the Securities Act for complying with new or revised accounting standards. In other words, an emerging growth company can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. We have elected to take advantage of the benefits of this extended transition period. Our financial statements may therefore not be comparable to those of companies that comply with such new or revised accounting standards.

RESULTS OF OPERATION

Results of Operations for the three months ended March 31, 2025, and 2024:

Revenue for three months ended March 31, 2025, and 2024

For the three months ended March 31, 2025, and 2024, we did not generate any revenue.

 16Table of Contents

Operating expenses for the three months ended March 31, 2025, and 2024

Total operating expenses for the three months ended March 31, 2025, were $34,849 which included depreciation and amortization expenses of $7,299, professional fees of $22,500 and share-based compensation $5,050.

Total operating expenses for the three months ended March 31, 2024, were $12,134 which included amortization on convertible promissory note $1,863, depreciation and amortization expense of $7,372, general and administrative expenses of $1,899, and professional fees of $1,000.

Net Loss

The net profit loss for the three months ended March 31, 2025, and 2023 was $(4,530) and $(17,838) respectively.

Liquidity and Capital Resources

As of March 31, 2025 we had no cash, total liabilities were $300,776 and a working capital deficit of $